Dermatology Times has published a new clinical pointer covering two touchpoints of everyday dermatology practice: how clinicians screen aesthetic patients, and how they manage alopecia.

The piece is short. It's a tip, not a trial. But the subjects it raises sit squarely in the part of dermatology where money, expectation and medicine meet — the consult room.

Why does screening come first in aesthetics?

Every aesthetic visit begins with a decision that has nothing to do with devices. It's the question of who should be in the chair at all. Screening is where clinicians catch the mismatch between what a patient wants and what a treatment can deliver.

The Dermatology Times tip addresses that front-end step directly. It reads as a reminder that patient selection is a clinical skill in its own right, not paperwork before the interesting part.

That matters now. Aesthetic demand keeps growing, and practices see more first-time patients with uneven expectations. A short, repeatable screening habit protects both sides of the encounter.

What about the alopecia angle?

Hair-loss care shares the same underlying discipline. Alopecia is not one diagnosis. It's a family of them, and the first job is telling them apart.

The tip folds alopecia management into the same practical frame as aesthetic screening. That pairing makes sense: both depend on history-taking, honest expectation-setting, and follow-up rather than a single intervention.

Takeaway: the consult, not the device or the prescription, is where outcomes start in both settings.

What should practices take from it?

Dermatology Times positions this as advice clinicians can apply immediately. The format is a tip — the kind of guidance senior editors run when they want a behavior to change, not a literature review.

Readers looking for effect sizes or device parameters won't find them here. What they will find is a nudge toward two habits: screen aesthetic patients deliberately, and treat alopecia follow-through as seriously as initial diagnosis.

Expect Dermatology Times to keep returning to both themes. Aesthetic volume and alopecia presentations are both rising across dermatology, and the practices that standardize their screening and hair-loss workflows early will be the ones best placed when the fuller guidance lands.